2013
DOI: 10.1039/c3md00050h
|View full text |Cite
|
Sign up to set email alerts
|

Targeted cancer cell inhibition using multifunctional dendrimer-entrapped gold nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
27
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
7
2

Relationship

5
4

Authors

Journals

citations
Cited by 41 publications
(29 citation statements)
references
References 39 publications
(62 reference statements)
2
27
0
Order By: Relevance
“…These advantages of PAMAM dendrimers enable them to be used as an ideal multifunctional nanoplatform for both imaging and drug delivery applications. However, a thorough literature investigation reveals that there are few reports dealing with the incorporation of both imaging element and drug into a single dendrimer-based nanoplatform for cancer theranostic applications [36,40]. Not to mention that the developed nanoplatforms in the literature have not been completely investigated in terms of the in vivo performance of either cancer imaging or therapy.…”
Section: Introductionmentioning
confidence: 99%
“…These advantages of PAMAM dendrimers enable them to be used as an ideal multifunctional nanoplatform for both imaging and drug delivery applications. However, a thorough literature investigation reveals that there are few reports dealing with the incorporation of both imaging element and drug into a single dendrimer-based nanoplatform for cancer theranostic applications [36,40]. Not to mention that the developed nanoplatforms in the literature have not been completely investigated in terms of the in vivo performance of either cancer imaging or therapy.…”
Section: Introductionmentioning
confidence: 99%
“…The past decades have seen an increasing interest in the use of various nanoparticulate systems for therapeutics (drug and gene delivery) [1][2][3][4][5][6], diagnostics [7][8][9][10], and the combination of both therapeutics and diagnostics (theranostics) [11][12][13]. In particular, the use of nanoparticles (NPs) as a drug carrier is able to overcome some of the current drawbacks of conventional cancer ligands, imaging agents, and anticancer drugs for simultaneous targeting, imaging, and therapeutic treatment of cancer cells [23][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%
“…A variety of nanoplatforms, including but not limited to iron oxide nanoparticles (NPs) [1][2][3], quantum dots [4,5], carbon nanotubes [6,7], gold NPs (AuNPs) [8,9], dendrimers [10][11][12], and silica NPs [13,14] have been functionalized to have both imaging and therapeutic functionalities. The major concern to build up a theranostic nanoplatform is to render the nanoplatforms with capacity to load both imaging (e.g., contrast agents) and therapeutic (e.g., drug) elements within a single nanoparticulate system.…”
Section: Introductionmentioning
confidence: 99%
“…These characteristics of dendrimers make them an ideal platform for theranostics of cancer. However, dendrimer-based theranostic nanosystems having both imaging and therapeutic functionalities have been rarely reported [10][11][12]35]. In our previous study [12], we utilized generation 5 (G5) poly(amidoamine) (PAMAM) dendrimers as a platform to link PEGylated folic acid (FA) and PEGylated ␣-tocopheryl succinate (␣-TOS) on the dendrimer periphery and to entrap AuNPs within the dendrimer interior.…”
Section: Introductionmentioning
confidence: 99%